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In the normal manner (NAST), between 8 and 9am bacterial isolates were inoculated in the Vitek system (bioMerieux, St Louis, Mo) . During the day shift (7 am to 3:30 pm) approximately half of the Vitek reports were ready to be verified and were verified by a technologist. If the data were acceptable, they were verified electronically in the Vitek system and automatically downloaded to the laboratory information system (LIS). The verified data were available to the physicians via computer access to the LIS at any time. At 10pm each night (once every 24 hours) a printed copy of all laboratory reports was generated and was available to the physicians making rounds the following morning. The reports, which were not yet ready to be verified in the day shift, were verified between 7 and 9am the next day.
For the RAST group, the procedure was exactly the same, except that a technologist on the second (evening) shift was scheduled to verify the reports, which became ready for verification after the day shift was over. Evening-shift verification was done at about 8:30 pm and took less than an hour. Data, which were verified on the second shift, were included in the cumulative report generated in 10pm.
The data for the patients' stays in the hospital were analysed. The physicians were not aware of any change of practice in microbiology.
Analysis of effectiveness
The intervention was comprehensive for all samples during the respective time periods, therefore more closely resembling intention to treat analysis. All categories of diagnosis-related groups (DRGs) for patients in the RAST group and the matching categories of DRGs for patients in the NAST group were included. The primary benefits analysed were the turnaround time (time from the receipt of a sample in the laboratory to the incorporation of verification of first AST result in the laboratory information system (LIS)), mortality, length of stay, orders and timing of antimicrobial agents.
The two patients groups were comparable in terms of age and severity code of DRGs and differed only in terms of the turnaround time.
A review of the medical records of 75 patients from the NAST and 75 patients from the RAST groups (quasi-randomly selected) was performed to determine whether physicians prescribed appropriate antimicrobial therapy sooner for RAST patients.
Effectiveness results
Approximately 50% of NAST sample results and 90% of RAST sample results were verified by the end of first day.
The average turnaround time for the reporting of AST results for all patients was 39.2 hours for the RAST group and 44.4 hours for the NAST group. The difference of 5.2 hours was statistically significant, (p=0.001).
The mortality rate for the RAST group was 7.9% and for the NAST group was 9.6%, (not statistically significant).
The average length of stay was 10.7 days in the RAST group and 12.6 days in the NAST group, (statistically significant difference of 2.0 days, p=0.006).
The percentage of patients for whom appropriate antimicrobial therapy was initiated within 48 hours of receipt of their samples in the laboratory was 94% for the RAST group and 77% for the NAST group, (statistically significant difference, p<0.006).
